Search

everythinglearnresearchcommunity

for

Search:↓

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Certain gene changes in osteopontin are linked to higher risk of atopic dermatitis and asthma.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Janus kinase inhibitors show promise for treating alopecia areata in children.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Hidradenitis suppurativa might be a type of autoinflammatory skin disease.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

Certain plasma proteins and genes are linked to obstructive sleep apnea, suggesting potential new treatments.

Doctors need more training in skin cancer screening, a new treatment is effective for a skin condition, better diagnosis methods for skin cancer are available, hair loss in women may be linked to hormones and cholesterol, certain skin care products might cause hair loss, babies' skin gets weaker after birth, and a gene mutation might be linked to eczema.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Vitiligo and alopecia areata may have similar causes despite their differences.

BCG site reactions after COVID-19 mRNA vaccination are mild, temporary, and likely under-reported.

Certain gene variants can influence acne risk and severity.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Ginsenoside Rd may help improve skin aging by increasing collagen in the skin.

Higher leptin levels link to hair loss.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Hair follicles play a crucial role in regulating skin barrier function.

Acne involves increased lipid production and inflammation, affecting skin cell behavior and treatment resistance.

Lactate is vital for skin health, influencing metabolism, the skin barrier, immune responses, and has therapeutic potential for skin disorders.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.